Middle East & Africa dPCR and qPCR Market Forecast to 2030
Middle East & Africa dPCR and qPCR Market Forecast to 2030 – Regional Analysis – By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), and End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Development of Droplet Digital PCR Drives Middle East & Africa dPCR and qPCR Market
Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, development of ddPCR would become a major trend in the Middle East & Africa dPCR and qPCR market in the future.
Middle East & Africa dPCR and qPCR Market Overview
The Middle East & Africa dPCR and qPCR market in the Middle East & Africa is segmented into UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The region is expected to experience a significant growth due to increase in developments of varied reagent systems and automated systems in this region, introduction of a wide range of new products in diagnostic laboratories, and growing number of conferences, meetings, workshops and symposiums is expected to grow the molecular diagnostics awareness market in Middles East & Africa region.
Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa dPCR and qPCR Market Segmentation
The Middle East & Africa dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.
Based on treatment, the Middle East & Africa dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.
By product, the Middle East & Africa dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.
By application, the Middle East & Africa dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.
By end user, the Middle East & Africa dPCR and qPCR market is segmented into segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.
Based on country, the Middle East & Africa dPCR and qPCR market is segmented into segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa dPCR and qPCR market in 2022.
Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Middle East & Africa dPCR and qPCR market.
Summary Info
Industry: | |
---|---|
Pricing options: | |
Geographical coverage: | |
Year of Publication: |
According to the Research Team’ research, the Middle East & Africa dPCR and qPCR market was valued at US$ 359.30 million in 2022 and is expected to reach US$ 504.97 million by 2030, registering a CAGR of 4.3% from 2022 to 2030. Growing adoption of PCR methods in emerging countries and development of droplet digital PCR are among the critical factors attributed to the Middle East & Africa dPCR and qPCR market expansion.
In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the Middle East & Africa dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.
On the contrary, high costs of PCR systems hampers the growth of Middle East & Africa dPCR and qPCR market.
Based on treatment, the Middle East & Africa dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held 69.7% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 250.52 million. It is projected to garner US$ 365.48 million by 2030 to expand at 4.8% CAGR during 2022-2030.
By product, the Middle East & Africa dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 64.5% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 231.58 million. It is projected to garner US$ 339.38 million by 2030 to expand at 4.9% CAGR during 2022-2030.
By application, the Middle East & Africa dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held 56.4% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 202.67 million. It is projected to garner US$ 310.23 million by 2030 to expand at 5.5% CAGR during 2022-2030. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.
By end user, the Middle East & Africa dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held 56.4% share of the Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 202.67 million. It is projected to garner US$ 310.23 million by 2030 to expand at 5.5% CAGR during 2022-2030.
Based on country, the Middle East & Africa dPCR and qPCR market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held 35.9% share of Middle East & Africa dPCR and qPCR market in 2022, amassing US$ 128.82 million. It is projected to garner US$ 191.67 million by 2030 to expand at 5.1% CAGR during 2022-2030.
Key players operating in the Middle East & Africa dPCR and qPCR market are Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the dPCR and qPCR market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa dPCR and qPCR Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
5. Middle East & Africa dPCR and qPCR Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Genetic and Infectious Diseases
5.1.2 Rising Investments and Funds for Gene Synthesis
5.1.3 Technological Advancements in PCR Technologies
5.2 Market Restraints
5.2.1 High Costs of PCR Systems
5.2.2 Technical Limitations Associated with qPCR
5.3 Market Opportunities
5.3.1 Growing Adoption of PCR Methods in Emerging Countries
5.4 Future Trends
5.4.1 Development of Droplet Digital PCR
5.5 Impact Analysis:
6. dPCR and qPCR Market – Middle East & Africa Market Analysis
6.1 Middle East & Africa dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
7. Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
7.3 Quantitative PCR
7.3.1 Overview
7.3.2 Quantitative PCR: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Digital PCR
7.4.1 Overview
7.4.2 Digital PCR: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
8.1 Overview
8.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
8.3 Reagents & Consumables
8.3.1 Overview
8.3.2 Reagents & Consumables: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Instruments
8.4.1 Overview
8.4.2 Instruments: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Software & Services
8.5.1 Overview
8.5.2 Software & Services: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Research Application
9.3.1 Overview
9.3.2 Research Application: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Clinical Application
9.4.1 Overview
9.4.2 Clinical Application: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Middle East & Africa dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
9.5 Forensic Application
9.5.1 Overview
9.5.2 Forensic Application: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
10.1 Overview
10.2 Middle East & Africa dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
10.3 Hospitals and Diagnostic Centers
10.3.1 Overview
10.3.2 Hospitals and Diagnostic Centers: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Laboratories and Academic Institutes
10.5.1 Overview
10.5.2 Research Laboratories and Academic Institutes: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Forensic Laboratories
10.6.1 Overview
10.6.2 Forensic Laboratories: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Clinical Research Organizations
10.7.1 Overview
10.7.2 Clinical Research Organizations: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa dPCR and qPCR Market – Country Analysis
11.1.1.1 Middle East & Africa dPCR and qPCR Market, by Country
11.1.1.2 Saudi Arabia
11.1.1.2.1 Saudi Arabia: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.2 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.2.3 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.2.4 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.4.1 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.2.5 Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.3 UAE
11.1.1.3.1 UAE Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.2 UAE: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.3.3 UAE: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.3.4 UAE: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.4.1 UAE: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.3.5 UAE: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.4 South Africa
11.1.1.4.1 South Africa: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.2 South Africa: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.4.3 South Africa: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.4.4 South Africa: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.4.4.1 South Africa: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.4.5 South Africa: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11.1.1.5 Rest of Middle East & Africa
11.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
11.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
11.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
11.1.1.5.4.1 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
11.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
12. dPCR and qPCR Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in Middle East & Africa dPCR and qPCR Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takara Bio Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Qiagen NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Standard BioTools Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 F. Hoffmann-La Roche Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Agilent Technologies Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa dPCR and qPCR Market Segmentation
Table 2. Middle East & Africa dPCR and qPCR Market, by Clinical Application – Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia: Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 8. UAE Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. UAE Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. UAE Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. UAE Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa: Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 14. South Africa: Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. South Africa: Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. South Africa: Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Recent Organic Growth Strategies in Middle East & Africa dPCR and qPCR Market
Table 24. Recent Inorganic Growth Strategies in the Middle East & Africa dPCR and qPCR Market
Table 25. Glossary of Terms, Middle East & Africa dPCR and qPCR Market
LIST OF FIGURES
Figure 1. Middle East & Africa dPCR and qPCR Market Segmentation, By Country
Figure 2. Middle East & Africa – PEST Analysis
Figure 3. Middle East & Africa dPCR and qPCR Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Middle East & Africa dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 7. Quantitative PCR: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Digital PCR: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 10. Reagents & Consumables: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Instruments: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Software & Services: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Middle East & Africa dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 14. Research Application: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Clinical Application: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Forensic Application: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Middle East & Africa dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 18. Hospitals and Diagnostic Centers: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Pharmaceutical and Biotechnology Companies: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories and Academic Institutes: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Forensic Laboratories: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Clinical Research Organizations: Middle East & Africa dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 24. Middle East & Africa dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Saudi Arabia: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. UAE: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Middle East & Africa: Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies in Middle East & Africa dPCR and qPCR Market
The List of Companies – Middle East & Africa dPCR and qPCR Market
1. Abbott Laboratories
2. Agilent Technologies Inc
3. Bio-Rad Laboratories Inc
4. F. Hoffmann-La Roche Ltd
5. Qiagen NV
6. Standard BioTools Inc
7. Takara Bio Inc
8. Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.